×
The Safety of Olanzapine in Adolescents With Schizophrenia or Bipolar I Disorder: A Pooled Analysis of 4 Clinical Trials PDF
$ 40.00
The Safety of Olanzapine in Adolescents With Schizophrenia or Bipolar I Disorder: A Pooled Analysis of 4 Clinical Trials PDF quantity
$ 40.00
×
Efficacy of Quetiapine Monotherapy for the Treatment of Depressive Episodes in Bipolar I Disorder: A Post Hoc Analysis of Combined Results From 2 Double-Blind, Randomized, Placebo-Controlled Studies PDF
$ 40.00
Efficacy of Quetiapine Monotherapy for the Treatment of Depressive Episodes in Bipolar I Disorder: A Post Hoc Analysis of Combined Results From 2 Double-Blind, Randomized, Placebo-Controlled Studies PDF quantity
$ 40.00
×
Supporting Patients With Autism During COVID-19 PDF
$ 40.00
Supporting Patients With Autism During COVID-19 PDF quantity
$ 40.00
×
Trajectories of Perinatal Depressive and Anxiety Symptoms in a Community Cohort PDF
$ 40.00
Trajectories of Perinatal Depressive and Anxiety Symptoms in a Community Cohort PDF quantity
$ 40.00
×
Relationships of Age at Onset With Clinical Features and Cognitive Functions in a Sample of Schizophrenia Patients PDF
$ 40.00
Relationships of Age at Onset With Clinical Features and Cognitive Functions in a Sample of Schizophrenia Patients PDF quantity
$ 40.00
×
Clozapine in Treatment-Resistant Patients With Schizophrenia, Schizoaffective Disorder, or Psychotic Bipolar Disorder: A Naturalistic 48-Month Follow-Up Study PDF
$ 40.00
Clozapine in Treatment-Resistant Patients With Schizophrenia, Schizoaffective Disorder, or Psychotic Bipolar Disorder: A Naturalistic 48-Month Follow-Up Study PDF quantity
$ 40.00
×
Improving Physical Health in Patients With Chronic Mental Disorders: Twelve-Month Results From a Randomized Controlled Collaborative Care Trial PDF
$ 40.00
Improving Physical Health in Patients With Chronic Mental Disorders: Twelve-Month Results From a Randomized Controlled Collaborative Care Trial PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart